Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DEXTROAMPHETAMINE SULFATE
- Study to Evaluate the Abuse Liability, Pharmacokinetics, Safety and Tolerability of an Abuse-Deterrent d-Amphetamine Sulfate Immediate Release Formulation (ADAIR)
- Pilot Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Abuse Liability of an Abuse-Deterrent Immediate-Release Formulation (ADAIR)
- Influence of Amphetamine-induced Sensitization on Dopamine Synthesis and Release
- Cannabioids as a New Intervention for Amphetamine Dependence
- A Study of Delayed and Extended Release Formulation of Dextroamphetamine Sulfate (HLD100) in Children With ADHD
- A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD)
- Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3
- Dextroamphetamine as an Adjunct in Cocaine Treatment - 1
Clinical trials list
click for details